The GLP-1 Paradox: Wegovy and Mounjaro Patients Shed Weight, but Walk Less
"First I’ll lose the weight, and then I’ll start exercising." It is a thought shared by almost anyone starting highly effective obesity medications...
Search results for "prescription drugs"
Mixing Meds and Supplements: Why Red Ginseng Demands Caution for Diabetics
Dietary supplements concentrate health-promoting ingredients into convenient, everyday forms. However, just because a product is marketed as...
Sweet Fruit, Bitter Risks: Why Experts Warn Against Pairing Grapefruit with Common Medications
Grapefruit is a subtropical fruit highly prized for its unique sweet-tart flavor, balancing a gentle sweetness with a...
The Cost of Over-Supplementing: How Everyday Pills Can Quietly Damage Liver and Kidneys
Many people take a cocktail of medications, vitamins, and dietary supplements daily, hoping to safeguard their health.
The Ozempic Multiplier: Why Lifestyle Habits Still Dictate Heart Health in the GLP-1 Era
It has been three months since I started my once-weekly Ozempic injection. My blood sugar is clearly under control, and...
From Relief to Toxicity: The Hidden Danger of Mixing Common Cold Medications
Many households keep a stock of leftover cold medicines, often accumulating various brands over time.
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
“Do pharmacies stay open on holidays, too?” A checklist for foreigners
One of the things foreign visitors to South Korea are often amazed by is that they can get medicine even on weekends or...
Benign Prostatic Hyperplasia Medication Linked to 52% Higher Risk of Acute Glaucoma
A large-scale study in South Korea has revealed that alpha-blockers—the most common treatment for benign prostatic...
Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”
Celltrion’s subcutaneous formulation for autoimmune diseases, “Zymfentra,” which launched in the United States, has...